Sign in to continue:

Sunday, July 26th, 2026

Hallmark Venture Group Assigns Traderverse Inc. Promissory Note Debt to SB Technology Holdings in Related Party Transaction

Hallmark Venture Group, Inc. Enters Material Debt Assignment Agreement: Key Details for Investors

Hallmark Venture Group, Inc. (OTC: HLLK) has announced a significant corporate event that could impact shareholders and the company’s share price. On May 28, 2026, Hallmark Venture Group entered into an Assignment of Debt Agreement with SB Technology Holdings, Inc., a Florida corporation whose common stock is traded on OTC Markets under the symbol VGLS.

Key Points of the Report

  • Date of Event: May 28, 2026
  • Filing Type: Current Report on Form 8-K
  • Nature of Transaction: Assignment of Debt Agreement
  • Counterparty: SB Technology Holdings, Inc. (“SB Tech”)
  • Asset Assigned: Traderverse Inc. Promissory Note (the “Traderverse Note”)
  • Consideration: \$1,000.00, determined as the fair market value of the impaired Traderverse Note
  • Basis of Assignment: “As is, where is,” non-recourse

Detailed Transaction Description

Hallmark Venture Group (“the Company” or “HLLK”) sold, assigned, and transferred all of its rights, title, and interest in the Traderverse Note to SB Tech. This transaction was executed on a non-recourse basis, meaning SB Tech assumes all risks related to the future performance of the Traderverse Note. The consideration for this assignment was \$1,000, which both parties agreed represents the fair market value of the Note given its currently impaired condition.

This agreement is a related party transaction and will be reported in Hallmark’s subsequent filings with the SEC, as required by Item 404 of Regulation S-K. The company notes that this action is intended to satisfy requirements regarding director conflicts of interest under Section 607.0832 of the Florida Business Corporation Act.

Potential Impact on Shareholders and Share Price

  • Related Party Transaction: The deal will be disclosed in future SEC reports, which may attract scrutiny regarding governance and potential conflicts of interest.
  • Impaired Asset Removal: By assigning the impaired Traderverse Note for cash consideration, Hallmark may improve its balance sheet and remove a non-performing asset. This could be viewed positively by investors seeking cleaner financials.
  • Transaction Transparency: The company is transparent about the impaired nature of the asset and the rationale for the consideration. The full text of the Assignment Agreement is filed as Exhibit 10.1 to the Form 8-K.
  • Emerging Growth Company Status: Hallmark Venture Group is identified as an “emerging growth company” under SEC rules, which may affect its compliance obligations and investor perceptions.

Important Shareholder Considerations

  • Price Sensitivity: The removal of the impaired asset may be viewed as a positive corporate governance step, but the low consideration (\$1,000) reflects the asset’s diminished value and may raise questions about the company’s asset quality.
  • Related Party Disclosure: Investors should monitor future SEC filings for additional details on related party transactions as required by Regulation S-K.
  • Financial Reporting: The transaction could potentially improve Hallmark Venture Group’s reported financials by eliminating a liability related to the impaired asset.

Other Notable Information

  • Trading Information: Hallmark Venture Group’s common stock trades on OTC Markets under the symbol HLLK.
  • Company Details: Business address in Escondido, CA; incorporated in Nevada; fiscal year ends December 31.

Conclusion

The assignment of the impaired Traderverse Note to SB Technology Holdings, Inc. for \$1,000 is a material event for Hallmark Venture Group, Inc. It signals the company’s intent to clean up its balance sheet and enhance transparency for investors. Shareholders should pay close attention to future disclosures regarding related party transactions and any changes in financial reporting resulting from this agreement. The transaction may impact the company’s share price due to improved asset quality and governance, but also raises questions about the value of company assets and related party dealings.


Disclaimer: This article is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell any securities. Investors should conduct their own due diligence and consult with a licensed financial advisor before making any investment decisions. The information is based on public filings and may be subject to change.

View HALLMARK VENTURE GROUP, INC. Historical chart here



Prelude Therapeutics Appoints Dr. Charles Morris as Chief Medical Officer to Advance Precision Oncology Pipeline

Prelude Therapeutics Appoints Dr. Charles Morris as Chief Me...

Noble Corporation Reports Strong Q1 2026 Results, $7.5 Billion Backlog, and Maintains 2026 Guidance

Noble Corporation Q1 2026 Earnings Report: Investor-Focused ...